Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H16N2OS |
| Molecular Weight | 284.376 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CC(=O)N1C2=CC=CC=C2SC3=C1C=CC=C3
InChI
InChIKey=HKUCYAHWPVLPFN-UHFFFAOYSA-N
InChI=1S/C16H16N2OS/c1-17(2)11-16(19)18-12-7-3-5-9-14(12)20-15-10-6-4-8-13(15)18/h3-10H,11H2,1-2H3
| Molecular Formula | C16H16N2OS |
| Molecular Weight | 284.376 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dacemazine is a derivative of phenothiazine which acts as an antagonist of a histamine H1 receptor. The compound demonstrates local anesthetic activity and reduced the spasms produced by acetylcholine and histamine. In combination with di-tert-butylnaphthalenesulfonate, dacemazine was marketed under tradename Codopectyl as a spasmolytic and antitussive agent.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:05:40 UTC 2023
by
admin
on
Sat Dec 16 16:05:40 UTC 2023
|
| Record UNII |
88D34UY0QI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2107547
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
m546
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID70199733
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
88D34UY0QI
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
5252
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
100000083991
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
SUB06883MIG
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
DACEMAZINE
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
C73047
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
68846
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY | |||
|
518-61-6
Created by
admin on Sat Dec 16 16:05:41 UTC 2023 , Edited by admin on Sat Dec 16 16:05:41 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
